Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
- PMID: 27038448
- PMCID: PMC4838529
- DOI: 10.1007/s10620-016-4143-0
Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome predicted to be the next global epidemic affecting millions of people worldwide. The natural course of this disease including its subtype, non-alcoholic steatohepatitis (NASH), is not clearly defined especially in the African-American segment of the US population.
Aims: To conduct a review of the global epidemiology of NAFLD with emphasis on US minority populations.
Methods: A thorough search of evidence-based literature was conducted using the Pubmed database and commercial web sources such as Medscape and Google Scholar.
Results: NAFLD and its subtype NASH are becoming the principal cause of chronic liver disease across the world. In the US, Hispanics are the most disproportionately affected ethnic group with hepatic steatosis, and elevated aminotransferase levels, whereas African-Americans are the least affected. Genetic disparities involved in lipid metabolism seem to be the leading explanation for the lowest incidence and prevalence of both NAFLD and NASH in African-Americans.
Conclusions: The unprecedented rise in the prevalence of NAFLD globally requires an initiation of population cohort studies with long-term follow-up to determine the incidence and natural history of NAFLD and its underrepresentation in African-Americans. Future studies should also focus on the delineation of the interplay between genetic and environmental factors that trigger the development of NAFLD and NASH.
Keywords: Epidemiology, obesity, African-Americans (AAs), nonalcoholic fatty liver disease (NAFLD); Insulin resistance (IR); Metabolic syndrome (MetS); Nonalcoholic steatohepatitis (NASH).
Conflict of interest statement
Disclosures:
The authors disclose no conflicts of interest relevant to this study.
Figures
References
-
- Anstee QM, McPherson S, Day CP. How big a problem is non-alcoholic fatty liver disease? BMJ. 2011;343:d3897. - PubMed
-
- Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37:1202–1219. - PubMed
-
- Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2008;196:696–703. - PubMed
-
- Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
